SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Preventive Visit — Richard Roundtree

PatientRichard Roundtree
Date of birth1975-07-09
IdentifiersMRN HR-ML015-SYN; SSN (made up) 000-15-8410
Document date2026-10-27
AuthorLeon Carrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic preventive visit before chemotherapy; no new complaints. [S]

History of Present Illness

Mr. Roundtree is a 51-year-old man with stage IIA, hormone receptor-positive, HER2-negative left breast cancer, treated by mastectomy and axillary dissection three weeks ago, who comes for his periodic preventive visit before chemotherapy starts next week. The scar is healed and he has nearly full movement of the left shoulder; the numbness under the left arm is unchanged. His echocardiogram four days ago was normal. The germline test result is not back yet. He is sleeping well, is back at the gym with light lower-body work, and has told only a few close friends about the diagnosis. He no longer needs pain medicine and has no fever, cough, or bone pain. [S]

ElementDetail
VisitPeriodic adult preventive visit, timed before chemotherapy
Active conditionsLeft breast cancer, stage IIA, after surgery; chemotherapy to start next week
MedicinesNone regularly; finished acetaminophen ten days ago
Recent resultsEchocardiogram normal (ejection fraction 62 percent); germline panel pending
Functional statusIndependent; light training; working

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, apart from the cancer
PsychosocialWorried about how chemotherapy will affect his work and appearance; close friends aware; wants the diagnosis kept private at work
TobaccoNever used tobacco
Alcohol and drugsTwo or three drinks a week (AUDIT-C 2); no other drug use
Physical activityRuns and trains most days before surgery; light training now
NutritionRegular meals; high protein; no supplements
SleepSeven hours a night
Sexual healthNo concerns before treatment; fertility and sexual effects of chemotherapy discussed with oncology
SafetyWears a seat belt; smoke detectors at home; no firearms in the home
Oral healthNo dental visit in the past year
Hearing and visionNo concerns; eye examination last year

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, night sweats, or weight loss since surgery
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo toothache or gum bleeding
CardiovascularNegativeNo chest pain, palpitations, or leg swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeNo change in bowel habit or bleeding
GenitourinaryNegativeNo urinary symptoms; no sexual concerns
MusculoskeletalPositiveMild tightness at the end of left shoulder movement; no bone pain
IntegumentaryNegativeScar healed; no new skin lesions
NeurologicalPositiveNumbness under the left arm since surgery; no weakness or tingling in the hands or feet
PsychiatricNegativeMood fair to good; PHQ-2 score 1
Hematologic and lymphaticNegativeNo arm swelling or easy bruising

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route2026-10-07 to 2026-10-17completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-27Body height188cmS
2026-10-27Body weight85kgS
2026-10-27Body mass index (BMI) [Ratio]24kg/m2S
2026-10-27Systolic blood pressure124mm[Hg]S
2026-10-27Diastolic blood pressure78mm[Hg]S
2026-10-27Heart rate72/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-27Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-10-27Total score [AUDIT-C]2{score}S
2026-10-27Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=200 mg/dLNormalS
2026-10-27Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=40 mg/dLNormalS
2026-10-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation112mg/dL<=129 mg/dLNormalS
2026-10-27Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS
2026-10-27Hemoglobin A1c/Hemoglobin.total in Blood5.3%<=5.6%NormalS

Physical Exam

Vital signs recorded on 2026-10-27; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and muscular; weight 85.0 kg, BMI 24.0
Head, eyes, ears, nose, and throatNormal; teeth and gums healthy on inspection
NeckNo nodes or thyroid enlargement
Chest wallLeft mastectomy scar healed, with no fluid collection, nodule, or redness; no mass, skin change, or nipple change elsewhere on the chest
Lymph nodesNo axillary, supraclavicular, or cervical nodes on either side
CardiovascularRegular rhythm at 72 per minute; no murmur
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; liver not enlarged
GenitourinaryDeferred at his request
MusculoskeletalLeft shoulder flexion 165 degrees and abduction 150 degrees; upper arm circumference 33.5 cm on the left and 33.5 cm on the right
SkinNo suspicious lesions
PsychiatricCalm and engaged; judgment and insight intact

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.122S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy bookedresolvedconfirmed N63.42S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D).

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, this seasonCompleted todayInactivated vaccine given today; a live vaccine is not used with chemotherapy
COVID-19 vaccine, this seasonCompleted todayGiven today, before chemotherapy
Pneumococcal vaccineCompleted todayPCV20 given today; recommended at 50 and older, and before chemotherapy
Recombinant zoster vaccineDueRecommended at 50 and older; to be given after chemotherapy, when the response will be better, unless oncology advises giving it during treatment
Hepatitis B screening and vaccinationOrderedTriple panel drawn today, as recommended for all adults and before chemotherapy; vaccination if not immune
Hepatitis C and HIV screeningOrderedOne-time screening recommended for all adults; no prior result; drawn with his consent today
Tetanus, diphtheria, and pertussis boosterUp to dateTdap five years ago
Blood pressure screeningCompleted today124/78 mmHg
Cholesterol screening and statin decisionCompleted todayTotal cholesterol 186, HDL 56, LDL 112 mg/dL; ten-year risk about 4 percent with no diabetes, hypertension, or smoking, so a statin is not recommended
Diabetes screeningCompleted todayHbA1c 5.3 percent; also a baseline before dexamethasone with chemotherapy
Colorectal cancer screeningDueDue from 45; no screening on record. A colonoscopy or a stool test will be arranged after chemotherapy
Prostate cancer screeningNot indicatedShared decision-making about PSA testing is recommended from 55. If the germline panel shows a BRCA2 variant, screening would start now
Lung cancer and abdominal aortic aneurysm screeningNot indicatedNever used tobacco
Depression screeningCompleted todayPHQ-2 score 1; PHQ-9 6 last week
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 2; advised to avoid alcohol in the days around each chemotherapy cycle
Dental examinationReferredNo dental visit in the past year; a check before chemotherapy is advised; booked this week
Eye examinationUp to dateLast year

Immunizations given today: Influenza vaccine, 2026-2027 season (inactivated); COVID-19 mRNA vaccine, 2026-2027 formula; Pneumococcal conjugate vaccine PCV20 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: First chemotherapy cycle next week with medical oncology. Hepatitis B, hepatitis C, and HIV results to oncology before cycle 1. Dental visit this week. Primary care review during chemotherapy, after the second cycle. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes before chemotherapy, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is getting through treatment, keeping working, and having his privacy respected. He chose not to record specific treatment preferences today. The plan will be revisited yearly and with any change in his health. [S]